Jane M Armer1, Bob R Stewart, Robin P Shook. 1. Jane M Armer, Professor, Sinclair School of Nursing (SSON), Director, Nursing Research, Ellis Fischel Cancer Center; Bob R Stewart, Professor Emeritus, College of Education, Adjunct Clinical Professor, SSON; Robin P Shook, Project Development Specialist, Lymphedema Research Project, SSON, University of Missouri, Columbia, USA.
Abstract
BACKGROUND: Quantification of lymphoedema (LE) has been problematic, and the reported incidence of LE varies greatly among women treated with surgery and radiation for breast cancer. AIMS: This study aims to describe LE occurrence over time among breast cancer survivors using four diagnostic criteria based on three measurement techniques. METHODS: Limb volume and symptom assessment data were followed after surgery every three months for 12 months, then every six months for 30 months. Limb volume changes (LVC) were measured by circumferences and by perometry, and by symptom experience via interview. Standard survival analysis methods identified when the criteria indicating LE were met. RESULTS: Trends in LE occurrence are reported for data from 211 participants. At 30 months post-treatment, LE incidence ranged from 41-91%, with 2cm being the highest estimation method and self-reported signs and symtoms (SS) the lowest. CONCLUSIONS: This 30-month analysis supports the previous 12-month analysis in finding the 2cm criteria as the most liberal definition of LE. Self-reporting of heaviness and swelling, along with 10% LVC, represented the most conservative definitions (41% and 45%, respectively).
BACKGROUND: Quantification of lymphoedema (LE) has been problematic, and the reported incidence of LE varies greatly among women treated with surgery and radiation for breast cancer. AIMS: This study aims to describe LE occurrence over time among breast cancer survivors using four diagnostic criteria based on three measurement techniques. METHODS: Limb volume and symptom assessment data were followed after surgery every three months for 12 months, then every six months for 30 months. Limb volume changes (LVC) were measured by circumferences and by perometry, and by symptom experience via interview. Standard survival analysis methods identified when the criteria indicating LE were met. RESULTS: Trends in LE occurrence are reported for data from 211 participants. At 30 months post-treatment, LE incidence ranged from 41-91%, with 2cm being the highest estimation method and self-reported signs and symtoms (SS) the lowest. CONCLUSIONS: This 30-month analysis supports the previous 12-month analysis in finding the 2cm criteria as the most liberal definition of LE. Self-reporting of heaviness and swelling, along with 10% LVC, represented the most conservative definitions (41% and 45%, respectively).
Authors: Sarah A McLaughlin; Mary J Wright; Katherine T Morris; Gladys L Giron; Michelle R Sampson; Julia P Brockway; Karen E Hurley; Elyn R Riedel; Kimberly J Van Zee Journal: J Clin Oncol Date: 2008-10-06 Impact factor: 44.544
Authors: John J Coen; Alphonse G Taghian; Lisa A Kachnic; Sherif I Assaad; Simon N Powell Journal: Int J Radiat Oncol Biol Phys Date: 2003-04-01 Impact factor: 7.038
Authors: Robin J Bell; Penelope J Robinson; Raychel Barallon; Pamela Fradkin; Max Schwarz; Susan R Davis Journal: Support Care Cancer Date: 2013-02-24 Impact factor: 3.603
Authors: Jeanette Ezzo; Eric Manheimer; Margaret L McNeely; Doris M Howell; Robert Weiss; Karin I Johansson; Ting Bao; Linda Bily; Catherine M Tuppo; Anne F Williams; Didem Karadibak Journal: Cochrane Database Syst Rev Date: 2015-05-21
Authors: Cynthia L Miller; Michelle C Specht; Melissa N Skolny; Nora Horick; Lauren S Jammallo; Jean O'Toole; Mina N Shenouda; Betro T Sadek; Barbara L Smith; Alphonse G Taghian Journal: Breast Cancer Res Treat Date: 2014-02-06 Impact factor: 4.872
Authors: James W Jakub; Alicia M Terando; Amod Sarnaik; Charlotte E Ariyan; Mark B Faries; Sabino Zani; Heather B Neuman; Nabil Wasif; Jeffrey M Farma; Bruce J Averbook; Karl Y Bilimoria; Travis E Grotz; Jacob B Jake Allred; Vera J Suman; Mary Sue Brady; Douglas Tyler; Jeffrey D Wayne; Heidi Nelson Journal: Ann Surg Date: 2017-01 Impact factor: 12.969
Authors: Katarina Y Karlsson; Imke Wallenius; Lena B Nilsson-Wikmar; Henrik Lindman; Birgitta B K Johansson Journal: Support Care Cancer Date: 2015-03-06 Impact factor: 3.603
Authors: Jason M Green; Sowjanya Paladugu; Xu Shuyu; Bob R Stewart; Chi-Ren Shyu; Jane M Armer Journal: Nurs Res Date: 2013 Mar-Apr Impact factor: 2.381
Authors: Mei R Fu; Deborah Axelrod; Amber A Guth; Francis Cartwright; Zeyuan Qiu; Judith D Goldberg; June Kim; Joan Scagliola; Robin Kleinman; Judith Haber Journal: Ann Surg Oncol Date: 2014-05-09 Impact factor: 5.344
Authors: Jean O'Toole; Lauren S Jammallo; Melissa N Skolny; Cynthia L Miller; Krista Elliott; Michelle C Specht; Alphonse G Taghian Journal: Crit Rev Oncol Hematol Date: 2013-06-16 Impact factor: 6.312